AORT

Artivion, Inc.

• NASDAQ·6h ago

  Artivion (AORT) Soars 5.3%: Is Further Upside Left in the Stock?

• Benzinga·20h ago

  Needham Reiterates Buy on Artivion, Maintains $58 Price Target

• TipRanks·1d ago

  Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Corbus Pharmaceuticals (CRBP) and Artivion (AORT)

• Benzinga·1d ago

  UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday

• TipRanks·1d ago

  Analysts Are Bullish on Top Healthcare Stocks: Artivion (AORT), LB Pharmaceuticals, Inc. (LBRX)

• NASDAQ·1d ago

  Artivion Secures FDA Approval For NEXUS Aortic Arch System

• NASDAQ·1d ago

  Artivion Gets FDA Nod For NEXUS Aortic Arch System

• TipRanks·1d ago

  Artivion’s PMA for Nexus Aortic Arch System approved by the FDA

• Benzinga·1d ago

  The FDA Approves Premarket Approval Application For NEXUS Aortic Arch System, Developed By Artivion's Partner; The Approval Entitles Artivion To Exercise Its Option To Acquire Endospan At Any Time Within 90 Days

• Simply Wall St·4d ago

  Should Artivion’s Q4 Revenue Miss Amid Strong Product Growth Require Action From AORT Investors?

• Simply Wall St·03/30 06:08

  Is It Too Late To Reassess Artivion (AORT) After Its Strong Multi Year Share Price Run?

• Simply Wall St·03/25 18:14

  Artivion (AORT) Valuation Check After Recent Share Price Pullback And Mixed Growth Signals

• Simply Wall St·03/14 18:29

  How Investors May Respond To Artivion (AORT) Analyst Optimism Around NEXUS Stent Graft Trial Results

• Seeking Alpha·03/13 19:00

  Catalyst Watch: Nvidia's GTC Conference, FOMC meeting, Okta event, and triple-witching day